Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Lung Neoplasms"
language:"English"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=language%3A%22English%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=language%3A%22English%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=language%3A%22English%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (6.438)
1
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China : Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) : Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC : A Randomized Trial of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC : A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Open Label, Multicenter, Real World Practice of Durvalumab in Lung Cancer (Imfinzi PMS) : Open Label, Multicenter, Real World Practice of Durvalumab in Lung Cancer (Imfinzi PMS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy : A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer : Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab : Phase I Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Administered Concurrently With Pembrolizumab
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial : Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer : A Phase 1 Open-Label Study of HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[644]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Lung Neoplasms
Filter aufheben
Sprache: Englisch
Medienart
6.438
Aufsätze
6.438
E-Artikel
6.438
E-Ressourcen
Zeitschriftentitel
6.438
ClinicalTrials.gov
Thema
6.438
610
Lung Neoplasms
5.162
Study Type: Interventional
3.618
Carcinoma, Non-Small-Cell Lung
2.315
Recruitment Status: Completed
1.970
Phase: Phase 2
1.574
Recruitment Status: Recruiting
1.212
Study Type: Observational
778
Phase: Phase 1
737
Small Cell Lung Carcinoma
696
Recruitment Status: Terminated
655
Phase: Phase 3
653
Medical Condition: Lung Cancer
640
Recruitment Status: Active, not recruiting
529
Recruitment Status: Unknown status
429
Carcinoma
396
Recruitment Status: Not yet recruiting
349
Medical Condition: Non-small Cell Lung Cancer
291
Phase: Phase 1, Phase 2
281
Medical Condition: Non Small Cell Lung Cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.936
2020-
2.387
2010-2019
115
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
Haven't found what you're looking for?
Wird geladen...